NCT00003962View on ClinicalTrials.gov

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1998

Primary Completion Date

June 30, 2000

Study Completion Date

June 30, 2000

Conditions
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

aldesleukin

Trial Locations (1)

21287

Johns Hopkins Oncology Center, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00003962 - Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter